Federal award (DEFINITIVE CONTRACT, fiscal year 2024)
Recipient: NEOVAXSYN INC
Awarding agency: Department of Health and Human Services / National Institutes of Health
Funding agency: Department of Health and Human Services / National Institutes of Health
Period of performance: 2024-08-01 to 2025-10-31
Current total value of award: $300000
Description: DEVELOPMENT OF A NEXT-GENERATION IMMUNOPREVENTION PLATFORM AGAINST HIV-1